<DOC>
	<DOCNO>NCT02521116</DOCNO>
	<brief_summary>To date two different instrument commercially available measure retinal oxygen saturation retinal vessel diameter : Dynamic Vessel Analyzer ( DVA ) Oxymap . Retinal oxygen saturation analysis base spectroscopic evaluation retinal fundus image . Up data compare instrument measurement retinal oxygen saturation vessel diameter available literature . Study objectives : To compare retinal oxygenation retinal vessel diameter healthy subject patient diabetic retinopathy retinal vein occlusion 2 commercially available system ( DVA , Oxymap T1 ) Study design : Open pilot study Study population : 30 healthy volunteer , age 18-80 year 30 type 2 diabetic patient mild moderate non-proliferative diabetic retinopathy , age 18-80 year 30 patient retinal vein occlusion , age 18-80 year Topically administer medication : Tropicamide ( Mydriaticum `` Agepha '' ® , Agepha , Vienna , Austria ) , dose : 1-2 drop per study day dilation pupil Oxybuprocainhydrochloride combine sodium fluorescein ( Thilorbin® , Alcon Pharma GmbH , Freiburg , Germany ) , dose : 1 drop one eye measurement intraocular pressure Nonylacidvanillylamide combine Nicotinic-acid -- ß-butoxyethylester ( Finalgon® , Boehringer Ingelheim RCV GmbH &amp; Co KG , Vienna , Austria ) : topical earlobe Methods : Dynamic vessel analyzer Oxymap T1 Blood pressure pulse rate measurement Applanation tonometry Oxygen carbon dioxide partial pressure measurement arterialize blood earlobe Main outcome variable : Difference oxygen saturation retinal vessel DVA Oxymap T1 The motive investigation compare data 2 commercially available instrument measurement retinal oxygen saturation retinal vessel diameter healthy subject well patient ocular disease associate alter retinal oxygenation . Comparative data system currently available . Data study allow comparison study perform different system . All oxygen measurement procedures non-invasive painless . Hence , risk/benefit ratio appear acceptable .</brief_summary>
	<brief_title>Comparison Retinal Oxygenation Retinal Vessel Diameters Healthy Subjects Patients With Diabetic Retinopathy Retinal Vein Occlusion Between DVA Oxymap</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Inclusion criterion healthy volunteer normal ophthalmic finding , ametropia &lt; 3 dpt men woman age 18 80 year Inclusion criterion diabetic patient type 2 diabetes mild moderate nonproliferative diabetic retinopathy men woman age 18 80 year Inclusion criteria patient retinal vein occlusion branch central retinal venous occlusion men woman age 18 80 year Any follow exclude subject study : participation clinical trial 3 week precede study symptom clinically relevant illness 3 week first study day pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>retinal oxygenation</keyword>
	<keyword>retinal vessel diameter</keyword>
	<keyword>Dynamic vessel analyzer ( DVA )</keyword>
	<keyword>Oxymap T1</keyword>
</DOC>